The Genetic Polymorphisms of NPPA:rs5065 and NPPB:rs198389 and Intermediate Phenotypes of Heart Failure in Polish Patients
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26104567 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Anna Gorący-Rosik und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Molecular Biochemistry, Pomeranian Medical University, 70-111 Szczecin, Poland. Hauptthemen laut MEDLINE: Heart Failure, Polymorphism, Single Nucleotide, Atrial Natriuretic Factor, Receptors, Atrial Natriuretic Factor. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Heart failure (HF) is a complex disease and a major cause of morbidity and mortality worldwide. Natriuretic peptides (NPs) are involved in the pathogenesis of HF, but their activity may be modified by polymorphisms in the genes encoding them. Aim: To examine the associations of NPPA:rs5065 and NPPB:rs198389 polymorphisms with the risk of HF and cardiovascular phenotypes in Polish patients with HF. The study group comprised 330 HF patients, and the control group comprised 206 healthy newborns. Genomic DNA was extracted from blood, and genotyping of both polymorphisms was performed using polymerase chain reaction–restriction fragment length polymorphism. There were no significant differences in the distributions of NPPA and NPPB genotypes between HF patients and controls. Within the HF group, there were no significant associations between the frequencies of type 2 diabetes, hypertension, left ventricular hypertrophy, or categories of left ventricular ejection fraction (LVEF) and the NPPA or NPPB variants. However, LVEF was significantly higher in NPPA CC homozygotes than in carriers of at least one T allele. The results of our study did not confirm an association between the NPPA:rs5065 or NPPB:rs198389 polymorphisms and predisposition to HF or HF intermediate phenotypes, except for LVEF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Molecular Biochemistry, Pomeranian Medical University, 70-111 Szczecin, Poland.
- Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland.
- Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, 70-111 Szczecin, Poland.
ORCID-Profile: Jakub Rosik, Klaudyna Lewandowska, Krzysztof Safranow, Andrzej Ciechanowicz
Zitieren
APA
Gorący-Rosik, A., Fic, M., Rosik, J., Lewandowska, K., Safranow, K., Ciechanowicz, A., & Gorący, I. (2025). The Genetic Polymorphisms of NPPA:rs5065 and NPPB:rs198389 and Intermediate Phenotypes of Heart Failure in Polish Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26104567
Vancouver
Gorący-Rosik A, Fic M, Rosik J, Lewandowska K, Safranow K, Ciechanowicz A, et al. The Genetic Polymorphisms of NPPA:rs5065 and NPPB:rs198389 and Intermediate Phenotypes of Heart Failure in Polish Patients. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26104567
BibTeX
@article{GorcyRosik2025,
author = {Gorący-Rosik, Anna and Fic, Mateusz and Rosik, Jakub and Lewandowska, Klaudyna and Safranow, Krzysztof and Ciechanowicz, Andrzej and Gorący, Iwona},
title = {The Genetic Polymorphisms of NPPA:rs5065 and NPPB:rs198389 and Intermediate Phenotypes of Heart Failure in Polish Patients},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26104567}
}
EUVIMED